Key takeaways:
Aspirin-exacerbated respiratory disease (AERD) is a combination of asthma, nasal polyps, and sinus congestion that worsen in reaction to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
The reason that people develop AERD is still unknown. But inflammation seems to play an important part in the condition.
Treatment for AERD is very similar to treatment for asthma and sinus conditions. There is also a treatment that uses increasing doses of aspirin to desensitize someone to the medication.
Aspirin-exacerbated respiratory disease (AERD) is a condition that develops in adults, often in their 20s or 30s. It involves problems with the sinuses and lungs that worsen in reaction to medications like aspirin.
Sinus problems usually come first with nasal congestion and changes in your sense of smell. This is caused by growths inside the nose and sinuses, called nasal polyps. Breathing symptoms from asthma tend to start a few years later. Taking aspirin or a non-steroidal anti-inflammatory drug (NSAID) like aspirin will worsen both sinus and breathing symptoms.
AERD can be hard to recognize because sinus problems and asthma are very common. So, here we will review what causes AERD, how to tell if you might have it, and how to treat it.
Breathe Better with Dulera
Dulera may help control and prevent symptoms of asthma. Pay as little as $199 with GoodRx.
At this time, experts still don’t understand exactly why people develop AERD. But inflammation seems to be an important part of the condition.
Inflammation is a normal reaction for everyone when there is an infection or injury. But people with AERD have higher than normal levels of inflammatory cells that line their nose, sinuses, and airways. These cells are called mast cells and eosinophils.
For reasons we don’t fully understand, the number of these cells increases even more anytime someone with AERD takes specific anti-inflammatory drugs. Medications like aspirin, ibuprofen (Advil, Motrin), and naproxen (Aleve, Naprosyn) all work by blocking a process in the body known as the cyclooxygenase pathway. And any medication that affects this pathway can cause AERD symptoms to worsen.
The reason that some people develop AERD is unknown. But researchers are trying to understand why it happens.
Here’s what they have found so far:
AERD and genetics: AERD is not a genetic condition and does not seem to run in families.
AERD and allergies: People with AERD often have allergies, but it is not an allergic condition. It works through very different pathways than a typical allergic reaction like anaphylaxis.
AERD and tobacco smoke: There seems to be some relationship between AERD and tobacco smoke, but it’s complicated. Children who grow up around tobacco smoke seem more likely to develop AERD in the future. But in adults with AERD, smoking might actually decrease their breathing symptoms and quitting might make symptoms worse.
More research still needs to be done on the possible causes of AERD.
AERD is a somewhat rare condition. It affects 1% to 2% of the general population. In comparison, around 8% of the U.S. population has asthma. And around 5% of the U.S. population struggles with chronic sinus problems.
But AERD is more common in people with asthma and chronic sinus problems. It affects up to 10% of this population.
Asthma and sinus problems are quite common. But not everyone with these conditions necessarily has AERD. AERD is different because it also involves a sensitivity to aspirin and other similar medications.
An AERD diagnosis does not need any medical testing. Someone is diagnosed with the condition when they have the following three things:
Asthma
Sinus problems
A past reaction to aspirin, ibuprofen, naproxen, or another NSAID
There is also a test that can be done to find out if you have AERD. This is called an aspirin challenge. It is a procedure that is done with a healthcare provider. You take a very small dose of aspirin and wait to see if you have a reaction. If you don’t, you are then given larger doses until you have a reaction. Because the test is done in a medical setting, your reaction can be treated appropriately.
There are many treatment options for AERD. Many of these are the same medications used to treat asthma and sinus problems. Inhalers and other asthma medications can treat asthma symptoms caused by AERD. And sinus surgery can treat the sinus symptoms of AERD. Medications used for chronic sinusitis and nasal polyps — such as steroid nasal sprays like fluticasone (Flonase, Xhance) — can also treat these symptoms.
There are also medications that can help with both asthma and sinus symptoms at the same time. These medications work by treating the underlying inflammation that leads to AERD. They include:
Leukotriene receptor antagonists, like montelukast: This is helpful with the overactive inflammation in AERD.
Corticosteroids, like prednisone and Medrol: These medications help with any kind of inflammation, including the kind in AERD. But these medications can have serious side effects and are generally used only for severe symptoms over short periods of time.
Biologic medications, like Dupixent: These are injected medications that can be very helpful for asthma, sinus symptoms, and nasal polyps. But they are generally very expensive.
There is no cure for AERD, but there is a procedure called aspirin desensitization. This procedure can help decrease the chronic symptoms of AERD. It also stops them from flaring up with medications like aspirin. This is important if someone needs to take aspirin for another health condition, like arthritis or heart disease.
Like an aspirin challenge, aspirin desensitization involves taking higher and higher doses of aspirin with the help of a healthcare provider. But, an aspirin desensitization is different because it is done more slowly and has a different goal.
Aspirin desensitization is done to gradually raise your body’s tolerance to aspirin. The procedure can take anywhere from 1 to 3 days. Unlike a challenge, a desensitization should go smoothly — hopefully without reactions. And it is especially important for your asthma symptoms to be well-controlled before starting the process. An aspirin desensitization procedure is complete when someone can tolerate at least a full dose of aspirin (325 mg).
Aspirin desensitization is an affordable and effective treatment for AERD. Around 85% of people report some benefit from it.
The procedure is not quite a cure though. After desensitization, it is important to keep taking at least the same dose of aspirin (325 mg) every day. If you stop taking aspirin for more than 2 or 3 days, the sensitivity will start to return. And it will need to be restarted at a provider’s office. If you miss more than 5 days, then the entire desensitization process will need to be repeated.
But aspirin desensitization is not for everyone. Aspirin can cause other side effects, like stomach problems and easy bleeding or bruising. Around 15% of people with AERD on daily aspirin will eventually stop because of side effects.
AERD is a somewhat rare disease. It is easy for it to go undiagnosed, or misdiagnosed as just asthma or sinus disease. Your symptoms are enough to diagnose AERD. But an aspirin challenge is one way to make sure you have the condition. There are many effective treatment options for AERD — each with different costs and benefits. And medications for asthma or nasal polyps can help improve your symptoms.
If you are curious about whether you could have this condition, talk to your provider. Not all providers are familiar with this condition. But your questions could be an important first step to getting treatments that can help.
American Academy of Allergy, Asthma & Immunology. (2018). Saving time for AERD patients during aspirin challenge and desensitization.
Asthma and Allergy Foundation of America. (2022). Asthma facts and figures.
Berges-Gimeno, M. P., et al. (2003). Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology.
Chang, J. E., et al. (2012). Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Annals of Allergy, Asthma & Immunology.
Dietz de Loos, D., et al. (2019). Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. Journal of Allergy and Clinical Immunology.
Hayashi, H., et al. (2018). Smoking cessation as a possible risk factor for the development of aspirin-exacerbated respiratory disease in smokers. Journal of Allergy and Clinical Immunology in Practice.
Johns, C. B., et al. (2014). Elevated total serum IgE in nonatopic patients with aspirin-exacerbated respiratory disease. American Journal of Rhinology & Allergy.
Kennedy, J. L., et al. (2016). Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future. American Journal of Rhinology & Allergy.
Laidlaw, T. M., et al. (2013). Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunology and Allergy Clinics of North America.
Lee, R. U., et al. (2010). Aspirin-exacerbated respiratory disease: Evaluation and management. Allergy, Asthma & Immunology Research.
Pleskow, W. W., et al. (1982). Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period. Journal of Allergy and Clinical Immunology.
Rajan, J. P., et al. (2015). Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. Journal of Allergy and Clinical Immunology.
White, A. A., et al. (2012). Aspirin-exacerbated respiratory disease: Update on pathogenesis and desensitization. Seminars in Respiratory and Critical Care Medicine.
White, A. A., et al. (2020). Aspirin-exacerbated respiratory disease: Update on medical management. The World Journal of Otorhinolaryngology - Head and Neck Surgery.